The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD
In this interview, Dr. Richard Carvajal, Associat…
Oncology Data Advisor · i3 Health
April 1, 20225m 15s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this interview, Dr. Richard Carvajal, Associate Professor of Medicine at Columbia University Irving Medical Center and editorial board member of Oncology Data Advisor, discusses the practice-changing significance of the approval of tebentafusp and delves further into future directions in the development of treatments for uveal melanoma.